Aaron Galaznik

Aaron Galaznik, M.D., serves as the Chief Scientific Officer at Carevive Systems, an oncology-focused health technology company. He was appointed to this position on February 15, 2022, bringing over 15 years of experience in real-world evidence (RWE) generation and data analytics strategies to the role.1

Educational Background

• Bachelor of Arts in Biology: Harvard University
• Doctor of Medicine: Weill Cornell Medicine
• MBA in Management, Healthcare: Wharton School, University of Pennsylvania.

Professional Experience

Before joining Carevive, Dr. Galaznik held significant positions in leading pharmaceutical companies:

• Head of RWE Research Solutions at Medidata, where he developed a center of excellence for patient-level longitudinal data.
• Senior Director of Global Outcomes Research at Takeda, focusing on outcomes evidence generation strategies for oncologic compounds.
• Senior Director of RWD and Analytics at Pfizer, overseeing the acquisition and utilization of longitudinal clinical datasets.1

Contributions at Carevive

In his role at Carevive, Dr. Galaznik leads all scientific and clinical activities, focusing on enhancing patient care through innovative data-driven insights. He emphasizes the importance of actionable data in optimizing cancer treatment and improving patient outcomes.1

Dr. Galaznik's expertise lies in bridging clinical trial data with real-world applications, making him a pivotal figure in advancing cancer care through technology and analytics.12